¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

°í·Á´ëÇб³±¸·Îº´¿ø (¿Â¶óÀÎ) 2021 °í·Á´ëÇб³ ¾È°úÇб³½Ç ½ÉÆ÷Áö¾ö : 2021-10-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
°í·Á´ëÇб³±¸·Îº´¿ø (¿Â¶óÀÎ) 2021 °í·Á´ëÇб³ ¾È°úÇб³½Ç ½ÉÆ÷Áö¾ö : 2021-10-24
±³À°ÀÏÀÚ : 2021-10-24
±³À°Àå¼Ò : ¿Â¶óÀΠ 
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021 °í·Á´ëÇб³ ¾È°úÇб³½Ç ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : °í·Á´ëÇб³±¸·Îº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¾È°ú  
´ã´çÀÚ : À±Ã¶¹Î
¿¬¶ôó : 031-412-4812  
À̸ÞÀÏ : yuncheolmin@korea.ac.kr      
±³À°Á¾·ù : ¾È°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í Àü°øÀÇ 10,000¿ø / Àü¹®ÀÇ 30,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ08:30~08:45 Dry AMD  À±Ã¶¹Î(°í·Á´ë) 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ08:45~09:00 Pachychoroidal spectrum disease  ¹éÁö¿ø(°¡Å縯´ë) 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ09:00~09:15 Typical wet AMD and RAP  ±èÀçÈÖ(±è¾È°úº´¿ø) 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ09:15~09:30 Recent update in management of neovascular AMD  ±èÀ¯Ã¶(°è¸í´ë) 
Åä·Ð 10-24 ¿Â¶óÀΠ09:30~09:40 Discussion  () 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ09:45~10:00 Retinopathy of prematurity  ±è»óÁø(¼º±Õ°ü´ë) 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ10:00~10:15 Branched retinal vein occlusion  ½Å¿ë¿î(ÇѾç´ë) 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ10:15~10:30 Central retinal vein occlusion  ±èÀ±Àü(¿ï»ê´ë) 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ10:30~10:45 Retinal vascular manifestations of systemic disease  ¼ÛÁöÈÆ(¾ÆÁÖ´ë) 
Åä·Ð 10-24 ¿Â¶óÀΠ10:45~10:55 Discussion  () 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ11:00~11:15 Diabetic retinopathy, neurodegeneration or microvasculopathy?  ¹Úµ¿È£(°æºÏ´ë) 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ11:15~11:30 Advances in imaging and applications in diabetic retinopathy  »ç°ø¹Î(¿µ³²´ë) 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ11:30~11:45 Diabetic macular edema, pathogenesis and treatment  Áö¿µ¼®(Àü³²´ë) 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ11:45~12:00 Recent updates in DRCR network trials  À±Ã¢±â(¼­¿ï´ë) 
Åä·Ð 10-24 ¿Â¶óÀΠ12:00~12:10 Discussion  () 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ12:15~12:30 Epiretinal membrane and lamellar hole  ±è¹Î(¿¬¼¼´ë) 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ12:30~12:45 Vitreomacular traction syndrome and macular hole  º¯Àͼö(ºÎ»ê´ë) 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ12:45~13:00 Retinal detachment and PVD associated peripheral retinal disorders  ±èÁöÅÃ(Áß¾Ó´ë) 
±³À°½Ã°£ 10-24 ¿Â¶óÀΠ13:00~13:15 Myopic maculopathy  ³²±â¿±(Ãæ³²´ë) 
Åä·Ð 10-24 ¿Â¶óÀΠ13:15~13:25 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" °í·Á´ëÇб³±¸·Îº´¿ø (¿Â¶óÀÎ) 2021 °í·Á´ëÇб³ ¾È°úÇб³½Ç ½ÉÆ÷Áö¾ö : 2021-10-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û [¿Â¶óÀÎ] 2021³âµµ ´ëÇÑ°¡Á¤ÀÇÇаúÀÇ»çȸ Ãß°èÇмú´ëȸ ¹× Á¦46ȸ ¿¬¼ö°­Á : 2021-10-24
´ÙÀ½±Û ºÐÀÚÆó¾Ï¿¬±¸È¸ Lung Cancer School 2021 : 2021-10-23
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
945 ºÎ»ê 2018 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ã߰躸¼ö±³À° (Motor symptoms of dementia) : 2018-10-13 0 904 2018-09-19
944 ºÎ»ê ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ Ãß°èÇмú´ëȸ : 2018-10-13 0 958 2018-09-19
943 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø Yonsei Lung Transplant Academy 2018 : 2018-10-13 0 811 2018-09-19
942 °æ³² â¿ø°æ»ó´ëº´¿ø Á¦3ȸ ´ëÇÑ°ß¡¤ÁÖ°üÀýÇÐȸ °æ»óÁöȸ Çмú´ëȸ : 2018-10-13 0 1,227 2018-09-19
941 ´ë±¸ °æºÏ´ëº´¿ø ´ëÇÑÇǺΰúÇÐȸ 2018³â Á¦2Â÷ ¸ð¹ß¿¬¼ö±³À° (ÁÖÁ¦: Å»¸ðÁõÀÇ Áø´Ü°ú Ä¡·á) : 2018-10-13 1 1,605 2018-09-19
940 ¼­¿ï 2018 ´ëÇѳúÀüÁõÇÐȸ 10¿ù º¸¼ö±³À°(Basics and updates in Epilepsy) : 2018-10-13 0 654 2018-09-19
939 Á¦ÁÖ Á¦ÁÖ´ëÇб³º´¿ø Á¦7ȸ ÇǺΰú Á¦ÁÖÁöºÎȸ ÇмúÁý´ãȸ : 2018-10-12 0 890 2018-09-19
938 ºÎ»ê ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ Ãß°èÇмú´ëȸ : 2018-10-12 1 1,697 2018-09-19
937 ¼­¿ï ´ëÇÑÀÓ»óÈ­ÇÐȸ 2018³â Ãß°èÇмú´ëȸ : 2018-10-12 0 777 2018-09-19
936 ¼­¿ï »õ·Î¿î ¾ÏÄ¡·áÀÇ ½Ã´ë°¡ ¿­¸®´Ù : 2018-10-10 0 1,080 2018-09-19
935 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ³»°ú °­»ç ¹× Àü°øÀÇ¿Í °³¿øÀǸ¦ À§ÇÑ Æ¯°­ : 2018-10-10 0 1,127 2018-09-19
934 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ 17th KSGE EUS Hands-on Workshop & EUS Summit 2018 & WISE 2018 (Module III) : 2018-10-07 0 1,168 2018-09-19
933 ¼­¿ï ¼­¿ï¼º¸ðº´¿ø ´ëÇÑÈäºÎ½ÉÀåÇ÷°ü¿Ü°úÀÇ»çȸ 2018³â Ãß°èÇмú´ëȸ : 2018-10-07 0 1,024 2018-09-19
932 ¼­¿ï ´ëÇÑ¿¹¹æÀÇÇÐȸ Á¦3±â¡¸Áö¿ª»çȸ °øÁߺ¸°Ç ÃÖ°í¸®´õ °úÁ¤¡¹9:°øÁߺ¸°Ç¿¡¼­ health communication : 2018-10-06 0 742 2018-09-19
931 ¼­¿ï °Ç±¹´ëº´¿ø ´ëÇѼչßÅéÇÐȸ Á¦ 3Â÷ ½ÉÆ÷Áö¿ò : 2018-10-06 0 788 2018-09-19
1341 | 1342 | 1343 | 1344 | 1345 | 1346 | 1347 | 1348 | 1349 | 1350
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷